Search results
Results From The WOW.Com Content Network
The effective treatment of MRSA with linezolid has been successful [87] in 87% of people. Linezolid is more effective in soft tissue infections than vancomycin. [89] [1] This is compared to eradication of infection in those with MRSA treated with vancomycin. Treatment with vancomycin is successful in approximately 49% of people. [1]
Once the bacterium has been identified as the cause of the illness, treatment is often in the form of antibiotics and, where possible, drainage of the infected area. However, many strains of this bacterium have become antibiotic resistant ; for those with these kinds of infection, the body's own immune system is the only defense against the ...
By 1950, 40% of hospital S. aureus isolates were penicillin-resistant; by 1960, this had risen to 80%. [106] Methicillin-resistant Staphylococcus aureus (MRSA, often pronounced / ˈ m ɜːr s ə / or / ɛ m ɑːr ɛ s eɪ /), is one of a number of greatly feared strains of S. aureus which have become resistant
Bullous impetigo is a bacterial skin infection caused by Staphylococcus aureus that results in the formation of large blisters called bullae, usually in areas with skin folds like the armpit, groin, between the fingers or toes, beneath the breast, and between the buttocks.
MRSA ST398 is resistant to many antimicrobial agents; therefore, treatment options for this strain are limited. [8] However, hospitalization and aggressive treatment to treat the symptoms of MRSA ST398 can be employed. And until more information about antimicrobial susceptibilities are known, the ST398 strain should be treated as MRSA is. [9]
Vancomycin is a glycopeptide antibiotic medication used to treat certain bacterial infections. [7] It is administered intravenously (injection into a vein) to treat complicated skin infections, bloodstream infections, endocarditis, bone and joint infections, and meningitis caused by methicillin-resistant Staphylococcus aureus. [8]
Cloxacillin is an antibiotic useful for the treatment of several bacterial infections. [1] This includes impetigo, cellulitis, pneumonia, septic arthritis, and otitis externa. [1] It is not effective for methicillin-resistant Staphylococcus aureus (MRSA). [2] It can be used by mouth and by injection. [1]
The estimated incidence is 1 in 15,000 exposures, and is more frequent in people over 55 years old, females, and those with treatment longer than 2 weeks. [ 6 ] It should be used with caution and monitored in the elderly, particularly with intravenous administration, due to a risk of thrombophlebitis .